No. 49 / 2024 Announces Financial Results for the First Nine Months of 2024 Continued strong progress across obesity pipeline with proprietary assets ready for Phase 2 backed by a solid financial ...

The severe asthma market is fueled by the rising prevalence of the condition, particularly in urban areas, alongside the emergence of innovative therapies ...

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected ...

It covers the pipeline drug profiles, including clinical and nonclinical ... of LYT-100 in patients with IPF in the first ...

Boehringer Ingelheim has halted development of an obesity drug from Gubra that it originally pledged to advance back in 2017, ...

One of Britain’s biggest gas companies has unveiled plans for a 60-mile “blue hydrogen” pipeline in the north of England amid a row with environmentalists over the technology. Cadent Gas ...

Pipeline companies largely quit adding new capacity following the pandemic, when shale production dried up and pipeline utilization plummeted. The 580-mile (933-km) Matterhorn Express pipeline is ...

The scene of urban decay is just the tip of a catastrophic economic breakdown in the country since a pipeline carrying oil that accounts for more than 90% of government revenue ruptured and dried ...

Explore our latest breakthroughs in Wet Age-Related Macular Degeneration Research. Learn more about our innovative pipeline ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...

(AP) — A federal appeals panel has temporarily halted two permits needed to begin construction on a pipeline project in Tennessee that will supply a natural gas plant. In a split 2-1 decision, the 6th ...